Market closed
Maze Therapeutics, Inc./$MAZE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Maze Therapeutics, Inc.
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
Ticker
$MAZE
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
125
Website
MAZE Metrics
BasicAdvanced
$408M
7.46
$1.25
-
-
Price and volume
Market cap
$408M
52-week high
$13.24
52-week low
$9.30
Financial strength
Current ratio
9.755
Quick ratio
9.52
Long term debt to equity
11.171
Total debt to equity
13.523
Management effectiveness
Return on assets (TTM)
23.07%
Return on equity (TTM)
50.47%
Valuation
Price to earnings (TTM)
7.456
Price to revenue (TTM)
0.133
Price to book
-0.07
Price to tangible book (TTM)
-0.07
Price to free cash flow (TTM)
0.299
Growth
Earnings per share change (TTM)
-102.85%
MAZE News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Maze Therapeutics, Inc. stock?
Maze Therapeutics, Inc. (MAZE) has a market cap of $408M as of April 05, 2025.
What is the P/E ratio for Maze Therapeutics, Inc. stock?
The price to earnings (P/E) ratio for Maze Therapeutics, Inc. (MAZE) stock is 7.46 as of April 05, 2025.
Does Maze Therapeutics, Inc. stock pay dividends?
No, Maze Therapeutics, Inc. (MAZE) stock does not pay dividends to its shareholders as of April 05, 2025.
When is the next Maze Therapeutics, Inc. dividend payment date?
Maze Therapeutics, Inc. (MAZE) stock does not pay dividends to its shareholders.
What is the beta indicator for Maze Therapeutics, Inc.?
Maze Therapeutics, Inc. (MAZE) does not currently have a Beta indicator.